{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T15:47:26Z","timestamp":1787845646694,"version":"build-2784847793"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,2,2]]},"DOI":"10.7759\/cureus.102857","type":"journal-article","created":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T04:13:56Z","timestamp":1770092036000},"source":"Crossref","is-referenced-by-count":1,"title":["Epithelial Neuroendocrine Neoplasms: Grading Based on the New WHO 2022 Guidelines"],"prefix":"10.7759","author":[{"given":"Rizwana","family":"Shaik","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inuganti","family":"Venkata Renuka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bakkamanthala","family":"S K Kanth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leela Lahari","family":"Arikathota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1159\/000080731","article-title":"Epidemiology of neuroendocrine tumours","volume":"80","author":"Taal BG","year":"2004","unstructured":"Taal BG, Visser O. Epidemiology of neuroendocrine tumours. Neuroendocrinology. 2004, 80:3-7. 10.1159\/000080731","journal-title":"Neuroendocrinology"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1007\/s002689900026","article-title":"Gastric carcinoids and neuroendocrine carcinomas: pathogenesis, pathology, and behavior","volume":"20","author":"Rindi G","year":"1996","unstructured":"Rindi G, Bordi C, Rappel S, La Rosa S, Stolte M, Solcia E. Gastric carcinoids and neuroendocrine carcinomas: pathogenesis, pathology, and behavior. World J Surg. 1996, 20:168-172. 10.1007\/s002689900026","journal-title":"World J Surg"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1023\/A: 1012272314550","article-title":"Epidemiology and survival in patients with carcinoid disease in the Netherlands: an epidemiological study with 2391 patients","volume":"12","author":"Quaedvlieg PF","year":"2001","unstructured":"Quaedvlieg PF, Visser O, Lamers CB, Janssen-Heijen ML, Taal BG. Epidemiology and survival in patients with carcinoid disease in the Netherlands: an epidemiological study with 2391 patients. Ann Oncol. 2001, 12:1295-1300. 10.1023\/A: 1012272314550","journal-title":"Ann Oncol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.athoracsur.2017.05.011","article-title":"Adjuvant chemotherapy does not confer superior survival in patients with atypical carcinoid tumors","volume":"104","author":"Anderson KL Jr","year":"2017","unstructured":"Anderson KL Jr, Mulvihill MS, Speicher PJ, et al.. Adjuvant chemotherapy does not confer superior survival in patients with atypical carcinoid tumors. Ann Thorac Surg. 2017, 104:1221-1230. 10.1016\/j.athoracsur.2017.05.011","journal-title":"Ann Thorac Surg"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtho.2022.10.002","article-title":"SCLC: epidemiology, risk factors, genetic susceptibility, molecular pathology, screening, and early detection","volume":"18","author":"Wang Q","year":"2023","unstructured":"Wang Q, G\u00fcm\u00fc\u015f ZH, Colarossi C, Memeo L, Wang X, Kong CY, Boffetta P. SCLC: epidemiology, risk factors, genetic susceptibility, molecular pathology, screening, and early detection. J Thorac Oncol. 2023, 18:31-46. 10.1016\/j.jtho.2022.10.002","journal-title":"J Thorac Oncol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2020.03.304","article-title":"Gastroenteropancreatic neuroendocrine neoplasms: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"31","author":"Pavel M","year":"2020","unstructured":"Pavel M, \u00d6berg K, Falconi M, Krenning EP, Sundin A, Perren A, Berruti A. Gastroenteropancreatic neuroendocrine neoplasms: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2020, 31:844-860. 10.1016\/j.annonc.2020.03.304","journal-title":"Ann Oncol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1007\/s12022-022-09708-2","article-title":"Overview of the 2022 WHO Classification of neuroendocrine neoplasms","volume":"33","author":"Rindi G","year":"2022","unstructured":"Rindi G, Mete O, Uccella S, et al.. Overview of the 2022 WHO Classification of neuroendocrine neoplasms. Endocr Pathol. 2022, 33:115-154. 10.1007\/s12022-022-09708-2","journal-title":"Endocr Pathol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1111\/pin.13266","article-title":"Neuroendocrine tumor G3 of bronchopulmonary origin and its classification","volume":"72","author":"Kasajima A","year":"2022","unstructured":"Kasajima A, Kl\u00f6ppel G. Neuroendocrine tumor G3 of bronchopulmonary origin and its classification. Pathol Int. 2022, 72:488-495. 10.1111\/pin.13266","journal-title":"Pathol Int"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtho.2016.11.2222","article-title":"Neuroendocrine tumors of the lung: Current challenges and advances in the diagnosis and management of well-differentiated disease","volume":"12","author":"Hendifar AE","year":"2017","unstructured":"Hendifar AE, Marchevsky AM, Tuli R. Neuroendocrine tumors of the lung: Current challenges and advances in the diagnosis and management of well-differentiated disease. J Thorac Oncol. 2017, 12:425-436. 10.1016\/j.jtho.2016.11.2222","journal-title":"J Thorac Oncol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2025.15798","article-title":"Epidemiology of neuroendocrine neoplasms in the US","volume":"8","author":"Dasari A","year":"2025","unstructured":"Dasari A, Wallace K, Halperin DM, et al.. Epidemiology of neuroendocrine neoplasms in the US. JAMA Netw Open. 2025, 8:e2515798. 10.1001\/jamanetworkopen.2025.15798","journal-title":"JAMA Netw Open"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19950701)76:1<106::aid-cncr2820760116>3.0.co;2-w","article-title":"Carcinoid tumors in Denmark 1978-1989 and the risk of subsequent cancers. A population-based study","volume":"76","author":"Westergaard T","year":"1995","unstructured":"Westergaard T, Frisch M, Melbye M. Carcinoid tumors in Denmark 1978-1989 and the risk of subsequent cancers. A population-based study. Cancer. 1995, 76:106-109. 10.1002\/1097-0142(19950701)76:1&lt;106::aid-cncr2820760116&gt;3.0.co;2-w","journal-title":"Cancer"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.30400","article-title":"The epidemiology of metastases in neuroendocrine tumors","volume":"139","author":"Riihim\u00e4ki M","year":"2016","unstructured":"Riihim\u00e4ki M, Hemminki A, Sundquist K, Sundquist J, Hemminki K. The epidemiology of metastases in neuroendocrine tumors. Int J Cancer. 2016, 139:2679-2686. 10.1002\/ijc.30400","journal-title":"Int J Cancer"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.4143\/crt.2012.44.3.157","article-title":"Current trends of the incidence and pathological diagnosis of gastroenteropancreatic neuroendocrine tumors (GEP-NETs) in Korea 2000-2009: multicenter study","volume":"44","author":"Cho MY","year":"2012","unstructured":"Cho MY, Kim JM, Sohn JH, et al.. Current trends of the incidence and pathological diagnosis of gastroenteropancreatic neuroendocrine tumors (GEP-NETs) in Korea 2000-2009: multicenter study. Cancer Res Treat. 2012, 44:157-165. 10.4143\/crt.2012.44.3.157","journal-title":"Cancer Res Treat"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1007\/s00535-014-0934-2","article-title":"Epidemiological trends of pancreatic and gastrointestinal neuroendocrine tumors in Japan: a nationwide survey analysis","volume":"50","author":"Ito T","year":"2015","unstructured":"Ito T, Igarashi H, Nakamura K, et al.. Epidemiological trends of pancreatic and gastrointestinal neuroendocrine tumors in Japan: a nationwide survey analysis. J Gastroenterol. 2015, 50:58-64. 10.1007\/s00535-014-0934-2","journal-title":"J Gastroenterol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1111\/ajco.12498","article-title":"Epidemiological features of gastroenteropancreatic neuroendocrine tumors in Chengdu city with a population of 14 million based on data from a single institution","volume":"12","author":"Guo LJ","year":"2016","unstructured":"Guo LJ, Wang CH, Tang CW. Epidemiological features of gastroenteropancreatic neuroendocrine tumors in Chengdu city with a population of 14 million based on data from a single institution. Asia Pac J Clin Oncol. 2016, 12:284-288. 10.1111\/ajco.12498","journal-title":"Asia Pac J Clin Oncol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1530\/ERC-13-0027","article-title":"Are G3 ENETS neuroendocrine neoplasms heterogeneous?","volume":"20","author":"V\u00e9layoudom-C\u00e9phise FL","year":"2013","unstructured":"V\u00e9layoudom-C\u00e9phise FL, Duvillard P, Foucan L, et al.. Are G3 ENETS neuroendocrine neoplasms heterogeneous?. Endocr Relat Cancer. 2013, 20:649-657. 10.1530\/ERC-13-0027","journal-title":"Endocr Relat Cancer"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.32007\/jfacmedbagdad.584271","article-title":"The clinico-epidemiologic characteristics of Iraqi patients with neuroendocrine tumors and their response to long acting octreotide","volume":"3","author":"Abdulfattah MK","year":"2016","unstructured":"Abdulfattah MK, Al-naqqash MA. The clinico-epidemiologic characteristics of Iraqi patients with neuroendocrine tumors and their response to long acting octreotide. J Fac Med Baghdad. 2016, 3:312-315. 10.32007\/jfacmedbagdad.584271","journal-title":"J Fac Med Baghdad"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-15-0548","article-title":"Well-differentiated neuroendocrine tumors with a morphologically apparent high-grade component: A pathway distinct from poorly differentiated neuroendocrine carcinomas","volume":"22","author":"Tang LH","year":"2016","unstructured":"Tang LH, Untch BR, Reidy DL, et al.. Well-differentiated neuroendocrine tumors with a morphologically apparent high-grade component: A pathway distinct from poorly differentiated neuroendocrine carcinomas. Clin Cancer Res. 2016, 22:1011-1017. 10.1158\/1078-0432.CCR-15-0548","journal-title":"Clin Cancer Res"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1007\/s12022-020-09628-z","article-title":"Morphologic variants of pancreatic neuroendocrine tumors: clinicopathologic analysis and prognostic stratification","volume":"31","author":"Xue Y","year":"2020","unstructured":"Xue Y, Reid MD, Pehlivanoglu B, et al.. Morphologic variants of pancreatic neuroendocrine tumors: clinicopathologic analysis and prognostic stratification. Endocr Pathol. 2020, 31:239-253. 10.1007\/s12022-020-09628-z","journal-title":"Endocr Pathol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1097\/PAS.0000000000000662","article-title":"A practical approach to the classification of WHO grade 3 (G3) well-differentiated neuroendocrine tumor (WD-NET) and poorly differentiated neuroendocrine carcinoma (PD-NEC) of the pancreas","volume":"40","author":"Tang LH","year":"2016","unstructured":"Tang LH, Basturk O, Sue JJ, Klimstra DS. A practical approach to the classification of WHO grade 3 (G3) well-differentiated neuroendocrine tumor (WD-NET) and poorly differentiated neuroendocrine carcinoma (PD-NEC) of the pancreas. Am J Surg Pathol. 2016, 40:1192-1202. 10.1097\/PAS.0000000000000662","journal-title":"Am J Surg Pathol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-020-07356-5","article-title":"World Health Organization grading classification for pancreatic neuroendocrine neoplasms: a comprehensive analysis from a large Chinese institution","volume":"20","author":"Yang M","year":"2020","unstructured":"Yang M, Zeng L, Ke NW, et al.. World Health Organization grading classification for pancreatic neuroendocrine neoplasms: a comprehensive analysis from a large Chinese institution. BMC Cancer. 2020, 20:906. 10.1186\/s12885-020-07356-5","journal-title":"BMC Cancer"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.5005\/jp-journals-10002-1280","article-title":"Rising incidence of neuroendocrine tumors in Singapore: an epidemiological study","volume":"30","author":"Prakash PS","year":"2020","unstructured":"Prakash PS, Wijerathne S. Rising incidence of neuroendocrine tumors in Singapore: an epidemiological study. World J Endoc Surg. 2020, 30:1-4. 10.5005\/jp-journals-10002-1280","journal-title":"World J Endoc Surg"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.21037\/jgo.2016.12.08","article-title":"Clinicopathologic study of neuroendocrine tumors of gastroenteropancreatic tract: a single institutional experience","volume":"8","author":"Uppin MS","year":"2017","unstructured":"Uppin MS, Uppin SG, Sunil CS, Hui M, Paul TR, Bheerappa N. Clinicopathologic study of neuroendocrine tumors of gastroenteropancreatic tract: a single institutional experience. J Gastrointest Oncol. 2017, 8:139-147. 10.21037\/jgo.2016.12.08","journal-title":"J Gastrointest Oncol"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-019-6412-8","article-title":"Exploring the current status of neuroendocrine tumours: a population-based analysis of epidemiology, management and use of resources","volume":"19","author":"Darb\u00e0 J","year":"2019","unstructured":"Darb\u00e0 J, Mars\u00e0 A. Exploring the current status of neuroendocrine tumours: a population-based analysis of epidemiology, management and use of resources. BMC Cancer. 2019, 19:1226. 10.1186\/s12885-019-6412-8","journal-title":"BMC Cancer"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1159\/000495806","article-title":"Clinicopathological profiling of lung carcinoids with a Ki67 index > 20","volume":"108","author":"Kasajima A","year":"2019","unstructured":"Kasajima A, Konukiewitz B, Oka N, et al.. Clinicopathological profiling of lung carcinoids with a Ki67 index &gt; 20. Neuroendocrinology. 2019, 108:109-120. 10.1159\/000495806","journal-title":"Neuroendocrinology"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1097\/PAS.0000000000000767","article-title":"High-grade neuroendocrine carcinoma of the lung with carcinoid morphology: a study of 12 cases","volume":"41","author":"Quinn AM","year":"2017","unstructured":"Quinn AM, Chaturvedi A, Nonaka D. High-grade neuroendocrine carcinoma of the lung with carcinoid morphology: a study of 12 cases. Am J Surg Pathol. 2017, 41:263-270. 10.1097\/PAS.0000000000000767","journal-title":"Am J Surg Pathol"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1159\/000502776","article-title":"Classification and prognostic stratification of bronchopulmonary neuroendocrine neoplasms","volume":"110","author":"Oka N","year":"2020","unstructured":"Oka N, Kasajima A, Konukiewitz B, et al.. Classification and prognostic stratification of bronchopulmonary neuroendocrine neoplasms. Neuroendocrinology. 2020, 110:393-403. 10.1159\/000502776","journal-title":"Neuroendocrinology"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/284943-epithelial-neuroendocrine-neoplasms-grading-based-on-the-new-who-2022-guidelines","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T04:14:00Z","timestamp":1770092040000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/284943-epithelial-neuroendocrine-neoplasms-grading-based-on-the-new-who-2022-guidelines"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,2]]},"references-count":27,"URL":"https:\/\/doi.org\/10.7759\/cureus.102857","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2,2]]}}}